Does Rallies show Form 4 insider transactions for PBYI?

Yes. Rallies tracks PBYI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PBYI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PBYI. It does not provide personalized investment advice.

PBYI (PUMA BIOTECHNOLOGY INC) Stock Analysis - Insider Trades

PUMA BIOTECHNOLOGY INC (PBYI) is a publicly traded Healthcare sector company. As of May 21, 2026, PBYI trades at $7.00 with a market cap of $346.63M and a P/E ratio of 13.95. PBYI moved +2.50% today. Year to date, PBYI is +17.68%; over the trailing twelve months it is +92.56%. Its 52-week range spans $2.32 to $7.90. Analyst consensus is neutral with an average price target of $5.00. Rallies surfaces PBYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PBYI stock inside the company?

Recent PBYI insider activity includes AUERBACH ALAN H sold 18.01K, HUNT DOUGLAS M sold 5.01K, NOUGUES MAXIMO F sold 6.41K, AUERBACH ALAN H sold 16.94K, and HUNT DOUGLAS M sold 3.97K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PBYI Key Metrics

Key financial metrics for PBYI
Metric	Value
Price	$7.00
Market Cap	$346.63M
P/E Ratio	13.95
EPS	$0.50
Dividend Yield	0.00%
52-Week High	$7.90
52-Week Low	$2.32
Volume	33
Avg Volume	0
Revenue (TTM)	$227.18M
Net Income	$24.38M
Gross Margin	74.46%

Recent PBYI Insider Trades

AUERBACH ALAN H sold 18.01K (~$105.89K) on Jan 7, 2026.
HUNT DOUGLAS M sold 5.01K (~$29.48K) on Jan 7, 2026.
NOUGUES MAXIMO F sold 6.41K (~$37.65K) on Jan 7, 2026.
AUERBACH ALAN H sold 16.94K (~$98.99K) on Jan 6, 2026.
HUNT DOUGLAS M sold 3.97K (~$23.22K) on Jan 6, 2026.

Latest PBYI News

Puma Biotechnology Q4 Revenue Hits $75.5M on $59.9M NERLYNX Sales — Feb 27, 2026
Puma Biotech Beats Q4 Estimates: EPS 20.8% Above, Revenues +11% — Feb 27, 2026

PBYI Analyst Consensus

1 analysts cover PBYI: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.00.

Common questions about PBYI

Who is trading PBYI stock inside the company?: Recent PBYI insider activity includes AUERBACH ALAN H sold 18.01K, HUNT DOUGLAS M sold 5.01K, NOUGUES MAXIMO F sold 6.41K, AUERBACH ALAN H sold 16.94K, and HUNT DOUGLAS M sold 3.97K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PBYI?: Yes. Rallies tracks PBYI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PBYI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PBYI. It does not provide personalized investment advice.